The effect of Anakinra on Quality-of-Life in a family with colchicine-resistant FMF

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/29754

Title:	The effect of Anakinra on Quality-of-Life in a family with colchicine-resistant FMF
Authors:	VAN DER HILST, Jeroen Lijnen, A.
Issue Date:	2015
Source:	Pediatric Rheumatology, 13(1), p. 108-108
Abstract:	About 5-10% of patients with FMF do not to colchicine treatment to control inflammation. In these patients anti-IL1 therapy seems to be effective in controlling inflammation, although clinical trials are lacking. However, many patients on Anakinra experience side effects including headache and injection-site reactions. How Anakinra treatment influences quality-of-life (QoL) in these patients is unknown.
Document URI:	http://hdl.handle.net/1942/29754
DOI:	10.1186/1546-0096-13-S1-P108
Rights:	2015 van der Hilst and Lijnen This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/ publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Category:	M
Type:	Journal Contribution
Appears in Collections:	Research publications

File	Description	Size	Format
published abstract.pdf	Published version	262.73 kB	Adobe PDF	View/Open

Check